0001209191-15-012708.txt : 20150212 0001209191-15-012708.hdr.sgml : 20150212 20150212162124 ACCESSION NUMBER: 0001209191-15-012708 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150210 FILED AS OF DATE: 20150212 DATE AS OF CHANGE: 20150212 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MEDIVATION, INC. CENTRAL INDEX KEY: 0001011835 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133863260 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 525 MARKET STREET STREET 2: 36TH FLOOR CITY: SAN FRANCISCO STATE: CA ZIP: 94105 BUSINESS PHONE: 415-543-3470 MAIL ADDRESS: STREET 1: 525 MARKET STREET STREET 2: 36TH FLOOR CITY: SAN FRANCISCO STATE: CA ZIP: 94105 FORMER COMPANY: FORMER CONFORMED NAME: ORION ACQUISITION CORP II DATE OF NAME CHANGE: 19960408 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Machado Clarence Patrick CENTRAL INDEX KEY: 0001311210 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-32836 FILM NUMBER: 15606515 MAIL ADDRESS: STREET 1: 201 SPEAR STREET, 3RD FLOOR CITY: SAN FRANCISCO STATE: CA ZIP: 94107 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2015-02-10 0 0001011835 MEDIVATION, INC. MDVN 0001311210 Machado Clarence Patrick C/O MEDIVATION, INC. 525 MARKET ST., 36TH FLOOR SAN FRANCISCO CA 94105 1 0 0 0 Common Stock 2015-02-10 4 M 0 36000 9.385 A 67500 D Common Stock 2015-02-10 4 S 0 700 101.27 D 66800 D Common Stock 2015-02-10 4 S 0 3400 102.37 D 63400 D Common Stock 2015-02-10 4 S 0 11200 103.66 D 52200 D Common Stock 2015-02-10 4 S 0 20700 104.35 D 31500 D Stock Option (Right to Buy) 9.385 2015-02-10 4 M 0 36000 0.00 D 2018-10-30 Common Stock 36000 71990 D Shares sold pursuant to a 10b5-1 plan. The shares were sold at prices between $101.085 and $101.80. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. The shares were sold at prices between $102.00 and $102.94. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. The shares were sold at prices between $103.00 and $103.99. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. The shares were sold at prices between $104.00 and $104.88. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. Fully vested. /s/ Jennifer Rhodes, Attorney-in-fact 2015-02-11